[HTML][HTML] A selective p53 activator and anticancer agent to improve colorectal cancer therapy
H Ramos, MIL Soares, J Silva, L Raimundo… - Cell Reports, 2021 - cell.com
Impairment of the p53 pathway is a critical event in cancer. Therefore, reestablishing p53
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
A selective p53 activator and anticancer agent to improve colorectal cancer therapy
H Ramos, MIL Soares, J Silva, L Raimundo… - CELL REPORTS, 2021 - iris.unitn.it
Impairment of the p53 pathway is a critical event in cancer. Therefore, reestablishing p53
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
A selective p53 activator and anticancer agent to improve colorectal cancer therapy
H Ramos, MIL Soares, J Silva, L Raimundo… - 2021 - agris.fao.org
Impairment of the p53 pathway is a critical event in cancer. Therefore, reestablishing p53
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
A selective p53 activator and anticancer agent to improve colorectal cancer therapy
H Ramos, MIL Soares, J Silva, L Raimundo… - Cell …, 2021 - pubmed.ncbi.nlm.nih.gov
Impairment of the p53 pathway is a critical event in cancer. Therefore, reestablishing p53
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
[HTML][HTML] A selective p53 activator and anticancer agent to improve colorectal cancer therapy
H Ramos, MIL Soares, J Silva, L Raimundo… - Cell Reports, 2021 - Elsevier
Impairment of the p53 pathway is a critical event in cancer. Therefore, reestablishing p53
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
[PDF][PDF] A selective p53 activator and anticancer agent to improve colorectal cancer therapy
H Ramos, MIL Soares, J Silva, L Raimundo… - Cell Reports, 2021 - academia.edu
Impairment of the p53 pathway is a critical event in cancer. Therefore, reestablishing p53
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
[PDF][PDF] A selective p53 activator and anticancer agent to improve colorectal cancer therapy
H Ramos, MIL Soares, J Silva, L Raimundo… - Cell Reports, 2021 - core.ac.uk
Impairment of the p53 pathway is a critical event in cancer. Therefore, reestablishing p53
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
[HTML][HTML] A selective p53 activator and anticancer agent to improve colorectal cancer therapy
H Ramos, MIL Soares, J Silva, L Raimundo… - Cell Reports, 2021 - cell.com
Impairment of the p53 pathway is a critical event in cancer. Therefore, reestablishing p53
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
A selective p53 activator and anticancer agent to improve colorectal cancer therapy.
H Ramos, MIL Soares, J Silva, L Raimundo… - Cell Reports, 2021 - europepmc.org
Impairment of the p53 pathway is a critical event in cancer. Therefore, reestablishing p53
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
A selective p53 activator and anticancer agent to improve colorectal cancer therapy
H Ramos, MIL Soares, J Silva, L Raimundo… - Cell …, 2021 - estudogeral.uc.pt
Impairment of the p53 pathway is a critical event in cancer. Therefore, reestablishing p53
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …
activity has become one of the most appealing anticancer therapeutic strategies. Here, we …